Antibiotic Resistance Pattern of Enterobacteriaceae Strains Isolated from Community Urinary Tract Infections in Algiers, Algeria

1 WHO. (2014). Global Report on Surveillance 2014. Search in Google Scholar

2 Horváth, J., Wullt, B., Naber, K. G., & Köves, B. (2020). Biomarkers in urinary tract infections–which ones are suitable for diagnostics and follow-up?. GMS infectious diseases, 8, https://doi.org/10.3205/id000068 Search in Google Scholar

3 World Health Organization. (2020). Target product profiles for needed antibacterial agents: enteric fever, gonorrhoea, neonatal sepsis, urinary tract infections and meeting report. Search in Google Scholar

4 Shankar, P. R. (2016). Book review: Tackling drug-resistant infections globally. Malaysia : School of Pharmacy and Pharmaceutical Science, https://doi.org/10.4103/2045-080x.186181 Search in Google Scholar

5 Aouf, A., Gueddi, T., Djeghout, B., & Ammari, H. (2018). Frequency and susceptibility pattern of uropathogenic Enterobacteriaceae isolated from patients in Algiers, Algeria. The Journal of Infection in Developing Countries, 12(04), 244-249, https://doi.org/10.4103/2045-080x.186181 Search in Google Scholar

6 Yagoubat, M., El-Hadj-Khelil, A. O., Malki, A., Bakour, S., Touati, A., & Rolain, J. M. (2017). Genetic characterisation of carbapenem-resistant Gram-negative bacteria isolated from the University Hospital Mohamed Boudiaf in Ouargla, southern Algeria. Journal of global antimicrobial resistance, 8, 55-59, https://doi.org/10.1016/j.jgar.2016.10.008 Search in Google Scholar

7 Breijyeh, Z., Jubeh, B., & Karaman, R. (2020). Resistance of gram-negative bacteria to current antibacterial agents and approaches to resolve it. Molecules, 25(6), 1340, https://doi.org/10.3390/molecules25061340 Search in Google Scholar

8 Takahashi, M., Hagiya, H., Higashionna, T., Nakano, Y., Sato, K., Haruki, Y., Haruki, M., Honda, H., Ogawa, H., Ueda, K., & Otsuka, F. (2022). Antimicrobial prescription practices for outpatients with uncomplicated cystitis in Japan. Scientific reports, 12(1), 5921, https://doi.org/10.1038/s41598-022-09946-8 Search in Google Scholar

9 Lee, D. S., Lee, S. J., & Choe, H. S. (2018). Community-acquired urinary tract infection by Escherichia coli in the era of antibiotic resistance. BioMed research international, 2018, https://doi.org/10.1155/2018/7656752 Search in Google Scholar

10 Monegro, A. F., Muppidi, V., & Regunath, H. (2022). Hospital acquired infections. Treasure Island (FL): StatPearls Publishing. Search in Google Scholar

11 Van Duin, D., & Paterson, D. L. (2016). Multidrug-resistant bacteria in the community: trends and lessons learned. Infectious disease clinics, 30(2), 377-390, doi: 10.1016/j.idc.2016.02.004 Open DOISearch in Google Scholar

12 Todorovic Markovic, M., Gottfredsson, M., Todorovic Mitic, M., & Gaini, S. (2019). Focus of infection and microbiological etiology in community-acquired infections in hospitalized adult patients in the Faroe Islands. BMC infectious diseases, 19(1), 1-11, https://doi.org/10.1186/s12879-018-3650-3 Search in Google Scholar

13 Odoki, M., Almustapha Aliero, A., Tibyangye, J., Nyabayo Maniga, J., Wampande, E., Drago Kato, C., Agwu, E., & Bazira, J. (2019). Prevalence of bacterial urinary tract infections and associated factors among patients attending hospitals in Bushenyi district, Uganda. International journal of microbiology, 2019, https://doi.org/10.1155/2019/4246780 Search in Google Scholar

14 Gillespie, W. A., Linton, K. B., Miller, A., & Slade, N. (1960). The diagnosis, epidemiology and control of urinary infection in urology and gynaecology. Journal of Clinical Pathology, 13(3), 187-194, https://doi.org/10.1136/jcp.13.3.187 Search in Google Scholar

15 Karah, N., Rafei, R., Elamin, W., Ghazy, A., Abbara, A., Hamze, M., & Uhlin, B. E. (2020). Guideline for urine culture and biochemical identification of bacterial urinary pathogens in low-resource settings. Diagnostics, 10(10), 832, https://doi.org/10.3390/diagnostics10100832 Search in Google Scholar

16 CLSI. (2020). M100-ED29: 2021 Performance Standards for Antimicrobial Susceptibility Testing. 30. Search in Google Scholar

17 Muthulakshmi, M., & Gopalakrishnan, S. (2017). Study on urinary tract infection among females of reproductive age group in a rural area of Kancheepuram district, Tamil Nadu. Int J Community Med Public Health, 4(10), 3915-21, https://doi.org/10.18203/2394-6040.ijcmph20174274 Search in Google Scholar

18 Hamamouchi, J., Qasmaoui, A., Halout, K., Charof, R., & Ohmani, F. (2021). Antibiotic resistance in uropathogenic enterobacteria. In E3S Web of Conferences (Vol. 319, p. 01102). EDP Science, https://doi.org/10.1051/e3sconf/202131901102 Search in Google Scholar

19 Klein, R. D., & Hultgren, S. J. (2020). Urinary tract infections: microbial pathogenesis, host–pathogen interactions and new treatment strategies. Nature Reviews Microbiology, 18(4), 211-226, https://doi.org/10.1038/s41579-020-0324-0 Search in Google Scholar

20 Bentroki, A. A., Gouri, A., Yakhlef, A., Touaref, A., Gueroudj, A., & Bensouilah, T. (2012). Résistance aux antibiotiques de souches isolées d’infections urinaires communautaires entre 2007 et 2011 à Guelma (Algérie). Ann Biol Clin, 70(6), 666-8, https://doi.org/10.1684/abc.2012.0760 Search in Google Scholar

21 Suhartono, S., Mahdani, W., Hayati, Z., & Nurhalimah, N. (2021). Species distribution of Enterobacteriaceae and non-Enterobacteriaceae responsible for urinary tract infections at the Zainoel Abidin Hospital in Banda Aceh, Indonesia. Biodiversitas Journal of Biological Diversity, 22(8), https://doi.org/10.13057/biodiv/d220826 Search in Google Scholar

22 Baizet, C., Ouar-Epelboin, S., Walter, G., Mosnier, E., Moreau, B., Djossou, F., & Epelboin, L. (2019). Decreased antibiotic susceptibility of Enterobacteriaceae causing community-acquired urinary tract infections in French Amazonia. Médecine et Maladies Infectieuses, 49(1), 63-68, https://doi.org/10.1016/j.medmal.2018.09.009 Search in Google Scholar

23 Al-Naqshbandi, A. A., Chawsheen, M. A., & Abdulqader, H. H. (2019). Prevalence and antimicrobial susceptibility of bacterial pathogens isolated from urine specimens received in rizgary hospital—Erbil. Journal of infection and public health, 12(3), 330-336, https://doi.org/10.1016/j.jiph.2018.11.005 Search in Google Scholar

24. Orrett, F. A. (2001). Urinary tract infections in general practice in a rural community in South Trinidad. Saudi medical journal, 22(6), 537-540. https://doi.org/10.1001/jama.1963.03700100157117 Search in Google Scholar

25. Litza, J. A., & Brill, J. R. (2010). Urinary Tract Infections. Primary Care - Clinics in Office Practice, 37(3), 491–507, https://doi.org/10.1016/j.pop.2010.04.001 Search in Google Scholar

26 Orrett, F. A., & Davis, G. K. (2006). A comparison of antimicrobial susceptibility profile of urinary pathogens for the years, 1999 and 2003. West Indian Medical Journal, 55(2), 95–99, https://doi.org/10.1590/S0043-31442006000200006 Search in Google Scholar

27 World Health Organization – WHO. (2021). “Antimicrobial resistanceitle,” vol. Retrieved. Search in Google Scholar

28 Lo, D. S., Barreira, E. R., & Gilio, A. E. (2019). A Brazilian survey of the antimicrobial susceptibility of 847 Escherichia coli isolates from community-acquired urinary tract infections. Urol Nephrol Open Access J, 7(4), 81-83, https://doi.org/10.15406/unoaj.2019.07.00249 Search in Google Scholar

29 Kang, C. I., Kim, J., Park, D. W., Kim, B. N., Ha, U. S., Lee, S. J., Yeo, J. K., Min, S. K., Lee, H., & Wie, S. H. (2018). Clinical practice guidelines for the antibiotic treatment of community-acquired urinary tract infections. Infection & chemotherapy, 50(1), 67, https://doi.org/10.3947/ic.2018.50.1.67 Search in Google Scholar

30 Sunjaya, D. B., Lennon, R. J., Shah, V. H., Kamath, P. S., & Simonetto, D. A. (2019). Prevalence and predictors of third-generation cephalosporin resistance in the empirical treatment of spontaneous bacterial peritonitis. Mayo Clinic Proceedings, 94(8), 1499–1508, https://doi.org/10.1016/j.mayocp.2018.12.036 Search in Google Scholar

31 Gupta, K., Hooton, T. M., Naber, K. G., Wullt, B., Colgan, R., Miller, L. G., Moran, G. J., Nicolle, L. E., Raz, R., Schaeffer, A. J., & Soper, D. E. (2011). International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clinical Infectious Diseases, 52(5), 103–120, https://doi.org/10.1093/cid/ciq257 Search in Google Scholar

32 Yandai, F. H., Ndoutamia, G., Nadlaou, B., & Barro, N. (2019). Prevalence and resistance profile of Escherichia coli and Klebsiella pneumoniae isolated from urinary tract infections in N'Djamena, Tchad. International Journal of Biological and Chemical Sciences, 13(4), 2065-2073, https://dx.doi.org/10.4314/ijbcs.v13i4.13 Search in Google Scholar

33 Kotb, D., Mahmoud, M., Mahdi, W., & Khairy, R. (2019). Prevalence and Antimicrobial Resistance of Urinary ract Infections in Upper Egypt. Minia Journal of Medical Research, 30(4), 78–85, https://doi.org/10.21608/mjmr.2022.221691 Search in Google Scholar

34 Yamaji, R., Rubin, J., Thys, E., Friedman, C. R., & Riley, L. W. (2018). Persistent pandemic lineages of uropathogenic Escherichia coli in a college community from 1999 to 2017. Journal of Clinical Microbiology, 56(4), 01834-17, https://doi.org/10.1128/JCM.01834-17 Search in Google Scholar

35 Bartoletti, R., Cai, T., Wagenlehner, F. M., Naber, K., & Bjerklund Johansen, T. E. (2016). Treatment of Urinary Tract Infections and Antibiotic Stewardship. European Urology, Supplements, 15(4), 81–87, https://doi.org/10.1016/j.eursup.2016.04.003 Search in Google Scholar

36 Tano, Z. N., Kobayashi, R. K., Candido, E. P., Dias, J. B., Perugini, L. F., Vespero, E. C., & Pavanelli, W. R. (2022). Susceptibility to first choice antimicrobial treatment for urinary tract infections to Escherichia coli isolates from women urine samples in community South Brazil. Brazilian Journal of Infectious Diseases, 26, https://doi.org/10.1016/j.bjid.2022.102366 Search in Google Scholar

37 Stuck, A. K., Täuber, M. G., Schabel, M., Lehmann, T., Suter, H., & Mühlemann, K. (2012). Determinants of quinolone versus trimethoprimsulfamethoxazole use for outpatient urinary tract infection. Antimicrobial Agents and Chemotherapy, 56(3), 1359–1363, https://doi.org/10.1128/AAC.05321-11 Search in Google Scholar

38 Benko, R., Matuz, M., Juhasz, Z., Bognar, J., Bordas, R., Soos, G., Hajdu, E., & Peto, Z. (2019). Treatment of cystitis by hungarian general practitioners: a prospective observational study. Frontiers in Pharmacology, 10, 1498, https://doi.org/10.3389/fphar.2019.01498 Search in Google Scholar

39 Aşkın, E., & Elçin Akduman, A. (2020). Evaluation of treatment applications and antibiotic resistance rates for community acquired urinary tract infections in turkey and a review of the literature, https://doi.org/10.4274/jus.galenos.2020.3532 Search in Google Scholar

40 Chen, H., Rao, H., He, P., Qiao, Y., Wang, F., Liu, H., Cai, M., & Yao, J. (2014). Potential toxicity of amphenicol antibiotic: binding of chloramphenicol to human serum albumin. Environmental Science and Pollution Research, 21, 11340-11348, https://doi.org/10.1007/s11356-014-3081-7 Search in Google Scholar

41 Carmona-Cartaya, Y., Hidalgo-Benito, M., Borges-Mateus, L. M., Pereda-Novales, N., González-Molina, M. K., & Quiñones-Pérez, D. (2022). Community-Acquired Uropathogenic Escherichia coli, Antimicrobial Susceptibility, and Extended-Spectrum Beta-Lactamase Detection. MEDICC Review, 24, 20–25, https://doi.org/10.37757/MR2022.V24.N2.2 Search in Google Scholar

42 Zanichelli, V., Huttner, A., Harbarth, S., Kronenberg, A., Huttner, B., & Swiss Centre For Antibiotic Resistance Anresis. (2019). Antimicrobial resistance trends in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis urinary isolates from Switzerland: retrospective analysis of data from a national surveillance network over an 8-year period (2009-2016). Swiss Medical Weekly, 149, w20110, https://doi.org/10.4414/smw.2019.20110 Search in Google Scholar

43 Joo Jung, H., & Young Lee, S. (2019). 1472. Non-Carbapenems for Treating Community-Associated Urinary Tract Infection Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae in Children. Open Forum Infectious Diseases, 6, https://doi.org/10.1093/ofid/ofz360.1336 Search in Google Scholar

44 Assawatheptawee, K., Treebupachatsakul, P., Luangtongkum, T., & Niumsup, P. R. (2022). Risk Factors for Community-Acquired Urinary Tract Infections Caused by Multidrug-Resistant Enterobacterales in Thailand. Antibiotics, 11(8), 1039, https://doi.org/10.3390/antibiotics11081039 Search in Google Scholar

45 Principi, N., & Esposito, S. (2016). Antimicrobial stewardship in paediatrics. BMC Infectious Diseases, 16, 1–8, https://doi.org/10.1186/s12879-016-1772-z Search in Google Scholar

46 Rocha, J. L., Tuon, F. F., & Johnson, J. R. (2012). Sex, drugs, bugs, and age: rational selection of empirical therapy for outpatient urinary tract infection in an era of extensive antimicrobial resistance. The Brazilian Journal of Infectious Diseases, 16(2), 115-121, https://doi.org/10.1016/S1413-8670(12)70291-X Search in Google Scholar

47 Pulcini, C., Clerc-Urmes, I., Attinsounon, C. A., Fougnot, S., & Thilly, N. (2019). Antibiotic resistance of Enterobacteriaceae causing urinary tract infections in elderly patients living in the community and in the nursing home: a retrospective observational study. Journal of Antimicrobial Chemotherapy, 74(3), 775-781, https://doi.org/10.1093/jac/dky488 Search in Google Scholar